- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 20, 2021
Product Development
The TAC universe grows beyond PROTACs
Inducing autophagy is becoming a popular strategy as targeting chimeras extend beyond protein degradation
BioCentury | Apr 28, 2016
Distillery Therapeutics
Therapeutics: Microtubule-associated protein 1 light chain 3 β (MAP1LC3B; LC3B)
Items per page:
1 - 3 of 3